Eag1 | HIF-1α | Coexpression | ||||
---|---|---|---|---|---|---|
Variables | r | p Value | r | p Value | r | p Value |
Age at operation | −0.108 | 0.257 | −0.047 | 0.626 | 0.077 | 0.417 |
BMI at operation | 0.209 | 0.235 | 0.356 | 0.063 | −0.406 | 0.032* |
Tumour size | −0.203 | 0.032* | −0.212 | 0.025* | 0.236 | 0.012* |
Lymph node status | −0.199 | 0.040* | −0.207 | 0.032* | 0.212 | 0.027* |
Tumour stage | −0.164 | 0.083 | −0.181 | 0.056 | 0.199 | 0.036* |
*p<0.05, r: correlation coefficient.
†Spearman's rank correlation coefficient was used to evaluate the correlation between the expression of Eag1 and HIF-1α and clinical parameters in cancer tissues. A rank-sum test was used to calculate the differences in tumour size, lymph node status and tumour stage of patients between the Eag1+ HIF-1α+ group and other cancer tissues.
BMI, body mass index; Eag1, ether á go-go 1; HIF-1α, hypoxia-inducible factor 1α.